Mind Medicine (MindMed) Inc. - Common Shares (NQ:MNMD)

15.02 UNCHANGED

Last Price Updated: 4:00 PM EST, Jan 14, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Mind Medicine (MindMed) Inc. - Common Shares

< Previous 1 2 3 4 5 6 7 8 9

...

34 35 Next >

Psyched: LSD, Psilocybin As Breakthrough Therapies, $14M Fed Grant For Ibogaine, Indiana's Research And More ↗

March 20, 2024

Via Benzinga

Topics Economy

The Next Great Biotech Boom Has Arrived

March 19, 2024

EQNX::TICKER_START (NYSE:JNJ),(NASDAQ:CMPS),(NASDAQ:MNMD),(NASDAQ:ATAI),(NYSE:ABBV) EQNX::TICKER_END

Via FinancialNewsMedia

Why Robinhood Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket ↗

March 14, 2024

Shares of Robinhood Markets, Inc. (NASDAQ: HOOD) rose sharply in today’s pre-market trading after the company reported February trading metrics.

Via Benzinga

Mind Medicine's Earnings Outlook ↗

February 27, 2024

Via Benzinga

Why Clover Health Investments Shares Are Trading Higher By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

March 13, 2024

Shares of Clover Health Investments, Corp. (NASDAQ: CLOV) rose sharply during Wednesday’s session after the company reported better-than-expected fourth-quarter revenue results and issued FY24...

Via Benzinga

FDA Grants Cybin Breakthrough Therapy Status For Major Depression Psilocybin Therapy, Company Announces Positive Clinical Data & Canadian $150M Private Placement ↗

March 13, 2024

Via Benzinga

Psychedelic Compound-Based Drug Stock, Mind Medicine, Up 56% Last Week ↗

March 11, 2024

The FDA has granted breakthrough designation to Mind Medicine's program for the treatment of generalized anxiety disorder.

Via Talk Markets

MindMed to Participate in the Leerink Partners 2024 Global Biopharma Conference

March 11, 2024

From MindMed

Via Business Wire

What A Trip: Psychedelic Medicine Company MindMed Shares Rocket 50% After Positive Data ↗

March 10, 2024

Shares of clinical stage biopharmaceutical company MindMed were heavily monitored on Friday after the stock rocketed higher during Thursday's cash session by more than 51% on more than 30x the...

Via Talk Markets

MindMeds Systematic Biotech Approach With New FDA Therapy Designation, 12-Week Clinical Data, Plus Expected $175M Proceeds ↗

March 08, 2024

Via Benzinga

S&P 500 Gains 1%; Kroger Earnings Top Views ↗

March 07, 2024

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining over 250 points on Thursday. The Dow traded up 0.34% to 38,793.79 while the NASDAQ rose 1.63% to 16,292.61. The...

Via Benzinga

Topics Stocks

Why HighPeak Energy Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

March 07, 2024

Shares of HighPeak Energy, Inc. (NASDAQ: HPK) fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter revenue results.

Via Benzinga

MindMed Receives FDA 'Breakthrough Therapy' Designation For LSD As Anxiety Treatment, Shares Positive Results About Related Clinical Trials ↗

March 07, 2024

Via Benzinga

What's Going On With MindMed Stock Thursday? ↗

March 07, 2024

MindMed shares are trading higher Thursday after the company received FDA breakthrough therapy designation and announced positive study data

Via Benzinga

Why Is MindMed (MNMD) Stock Up 32% Today? ↗

March 07, 2024

MindMed stock is heading higher on Thursday as MNMD investors celebrate it getting breakthrough designation from the FDA!

Via InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

March 07, 2024

Pre-market stock movers are worth checking out on Thursday to get an idea of the hottest stocks worth watching this morning!

Via InvestorPlace

Mind Medicine (MindMed) Inc. Announces Pricing of Underwritten Offering of Common Shares and Concurrent Private Placement

March 07, 2024

From Mind Medicine (MindMed) Inc.

Via Business Wire

MindMed Receives FDA Breakthrough Therapy Designation and Announces Positive 12-Week Durability Data From Phase 2B Study of MM120 for Generalized Anxiety Disorder

March 07, 2024

From Mind Medicine (MindMed) Inc.

Via Business Wire

Psyched: New Evidence Shows Psilocybin As Anxiety Therapy, Open-Source Learning For Therapists, Enveric's Licensing Deals And More ↗

March 04, 2024

Via Benzinga

Largest Psychedelic Compound-Based Drug Stocks Up 15% In February; Now Up 33% YTD ↗

March 01, 2024

The Psychedelic Compound-Based Drug Stocks Index was up 15.0% in February led by Incannex Healthcare which was up 55.1%.

Via Talk Markets

MindMed to Host Conference Call and Webcast to Discuss Data Update for MM120

March 01, 2024

From MindMed

Via Business Wire

MindMed's 2023 Financial Results And Business Recap: Milestones Amid Rising Expenses ↗

February 28, 2024

Via Benzinga

MindMed Reports 2023 Financial Results and Business Updates

February 28, 2024

From MindMed

Via Business Wire

MindMed to Host Conference Call and Webcast to Discuss 2023 Financial Results and Provide Business Update

February 22, 2024

From MindMed

Via Business Wire

Psychedelic Stocks Index Popped 8% Last Week, Led By Incannex ↗

February 18, 2024

IXHL 's increase was based on the successful completion of an Investigational New Drug meeting with the U.S. Food and Drug Administration regarding the development of CannQuit-N for tobacco smoking...

Via Talk Markets

Psychedelics Headlines: Trauma-Informed Care, Valentine's Day & MDMA, Academics On Drugs And More ↗

February 15, 2024

Via Benzinga

Psyched: Psychedelics & Sex, MDMA And Federal Approval, Canadians For End-Of-Life Care And More ↗

February 15, 2024

Via Benzinga

Why Is ARB IOT (ARBB) Stock Up 230% Today? ↗

February 13, 2024

ARB IOT stock is taking off on Tuesday after providing investors with a shareholder update and heavy trading of ARBB shares this morning.

Via InvestorPlace

Why Is MindMed (MNMD) Stock Up 8% Today? ↗

February 12, 2024

MindMed and other psychedelic stocks are rising today on news of an FDA priority review. Here's what this means for MNMD stock and its peers.

Via InvestorPlace

MindMed to Participate in the 34th Annual Oppenheimer Healthcare Life Sciences Conference

February 07, 2024

From MindMed

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9

...

34 35 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.